"I would be interested to know why IMU should have a market cap...

"I would be interested to know why IMU should have a market cap
of $200M at this point in time?"

Possible game changer.

Lots of reasons why B cell therapies are better than T cell. Your own body produces them, so they are likely to be safer and more effective. imu's therapy may "kick start" patient's bodies in to targeting cancer the way it should (or does in most of us).

Cancer immunotherapy sales expect to be over $100 billion by 2022.

imu's pipeline could replace all T cell therapies, as well as other cancer treatments.

Excellent group of scientists with proven oncology success, in the clinic and commercially.

High chance of success imho.

So what would you value something that has a high chance of success and could command over a 100 billions of dollars in annual sales?

https://www.prnewswire.com/news-rel...harmaceutical-industry-by-2020-300609848.html